Astrea Bioseparations (Cambridge, UK) has announced that it has expanded its manufacturing and warehousing capabilities in the US.
Located in Canton, Massachusetts, the 12,000-square-foot facility will expand the company’s US footprint and increase its workforce up to 9% over an 18‑month period. It will feature cleanroom laboratories for column packing services, offices, warehousing, and column assembly spaces.
“Expanding our presence in the US reflects growing demand for our chromatography products and services to support effective development and production of cutting-edge biologics, including cell and gene therapies,” said Chris Brown, operations director at Astrea Bioseparations. “The new site gives us greater capacity to support new and existing customers by providing innovative and high‑quality products, within market‑leading time frames, as well as offering local technical expertise.”
For more information, please visit: www.astreabioseparations.com